within Pharmacolibrary.Drugs.ATC.N;

model N06AA07
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.25,
    Cl             = 0.02,
    adminDuration  = 600,
    adminMass      = 70 / 1000000,   // mg → kg
    adminCount     = 1,
    Vd             = 0.022,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.0033333333333333335,
    Tlag           = 600
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>N06AA07</td></tr><td>route:</td><td>oral</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Lofepramine is a tricyclic antidepressant (TCA) primarily used in the treatment of major depressive disorder. It is considered to have a slightly more favorable side effect profile compared to other TCAs. Lofepramine is approved and is still prescribed in certain countries, including the UK, for depression management.</p><h4>Pharmacokinetics</h4><p>Estimated typical adult pharmacokinetic parameters for oral administration; direct publications of detailed compartmental PK parameters for lofepramine are lacking.</p><h4>References</h4><ol><li><p>Lancaster, SG, &amp; Gonzalez, JP (1989). Lofepramine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in depressive illness. <i>Drugs</i> 37(2) 123–140. DOI:<a href=\"https://doi.org/10.2165/00003495-198937020-00003\">10.2165/00003495-198937020-00003</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/2649353/\">https://pubmed.ncbi.nlm.nih.gov/2649353</a></p></li><li><p>Ghose, K, &amp; Spragg, BP (1989). Pharmacokinetics of lofepramine and amitriptyline in elderly healthy subjects. <i>International clinical psychopharmacology</i> 4(3) 201–215. DOI:<a href=\"https://doi.org/10.1097/00004850-198907000-00003\">10.1097/00004850-198907000-00003</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/2677125/\">https://pubmed.ncbi.nlm.nih.gov/2677125</a></p></li><li><p>Forshell, GP, et al., &amp; Tuck, JR (1976). Pharmacokinetics of lofepramine in man: relationship to inhibition of noradrenaline uptake. <i>European journal of clinical pharmacology</i> 9(4) 291–298. DOI:<a href=\"https://doi.org/10.1007/BF00561663\">10.1007/BF00561663</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/971713/\">https://pubmed.ncbi.nlm.nih.gov/971713</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end N06AA07;
